Fri, August 5, 2016
Thu, August 4, 2016
Wed, August 3, 2016

David Steinberg Maintained (SUPN) at Strong Buy with Increased Target to $28 on, Aug 4th, 2016

David Steinberg of Jefferies, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Strong Buy with Increased Target from $23 to $28 on, Aug 4th, 2016.

David has made no other calls on SUPN in the last 4 months.



There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Amsellem of "Piper Sandler" Downgraded from Buy to Hold on, Monday, July 18th, 2016